FIRN M Biotechnology company About companyDrugs ArticlesResearchQuestions and answersBooksnewsFor specialists Contacts To find Grippferon Research "Invitro" Clinical researches Ophthalmoferon All studies Gerpferon All studies Company news FIRN M presents a new drug at ROOF-18 15 october 2018 FIRN M at the Forum "Mother and Child-2018" 8 october 2018 Our preparations Artificial Tear Wagisept Multicenter prospective placebo-controlled study "Evaluation of the therapeutic efficacy, tolerability and safety of the drug" Grippferon, nose drops "in the treatment of acute respiratory viral infections and influenza in pregnant women" Studies of the therapeutic efficacy, tolerance and harmlessness of the drug "Grippferon, nose drops" in the treatment of acute respiratory viral infections and influenza in pregnant women were carried out at the Saratov State Medical University from April 15, 2004 to March 15, 2005 (Rector of SSMU, Corresponding Member of the Russian Academy of Medical Sciences , Professor, MD, P.V. Glybochko), as well as on the basis of the City Hospital No. 33 of Nizhny Novgorod (Honored Doctor of the Russian Federation V.I. Kozlov). In total, the study involved 80 pregnant patients aged 18 to 35 years with mild to moderate acute respiratory disease. All patients were divided into two groups of equal clinical value. The experimental group received the drug "Grippferon, nose drops" daily, 3 drops in each nasal passage 5-6 times during the day. The control group received a placebo instillation with the same frequency. In addition, in both groups, on average, antipyretics, antihistamines and desensitizing agents, antitussives, and vasoconstrictor nasal drops were equally used. In both the experimental and control groups, the disease in patients began acutely, with an increase in body temperature and hyperemia of the oropharyngeal mucosa. A number of patients had a cough and a runny nose. Результаты исследования В опытной и контрольной группах была выявлена статистически достоверная разница динамики таких клинических симптомов как: гиперемия слизистой ротоглотки, чихания, срока нормализации температуры. Кроме того, у больных, принимавших «Гриппферон» сократилась продолжительность течения ОРВИ. Так, нормализация температуры у больных из опытной группы наступала в среднем на 2 дня раньше, чем у больных из контрольной группы, примерно в два раза быстрее проходила гиперемия зева, отек слизистой носа, кашель и чихание. Длительность болезни у пациенток, принимавших «Гриппферон» составила 3−4 дня, а у пациенток из контрольной группы порядка 6−7 дней. It should be noted that two patients from the control group had complications (conjunctivitis, bronchitis), in one case it became necessary to prescribe antibiotics. No complications of the disease were recorded in the experimental group. All patients tolerated Grippferon, nose drops well. There were no cases of allergic reactions or other side effects. findings The use of "Grippferon" allows for 1-2 days to quickly stop the subjective and objective symptoms of acute respiratory viral infections in mild and moderate forms of the disease, as well as avoid the prescription of antibiotics and shorten the duration of the disease, which is of great importance for the treatment of pregnant women. Report on the results of testing the prophylactic efficacy of the drug "Grippferon - nose drops" in children On the results of a study of the therapeutic efficacy, harmlessness and tolerability of the drug "Grippferon, nose drops" for the treatment of acute respiratory viral infections in children of the first year of life. Questions and answers Recently asked: How often is it necessary to drip the drug so as not to get infected if contact with a sick person is constant? Ask your question We advise you to read Our books describe in detail the methods of influencing "active" points with needles, heat, electric current, vacuum; acupressure and hirudotherapy techniques. Contact information : firnm@grippferon.ru 8 495 956-15-43 Russia, Moscow, 127018, st. October, house 6 Dear site visitors! We remind you that the publications presented on the site should not be used for self-diagnosis and treatment of diseases and cannot serve as a substitute for a doctor's consultation. FVGO All contacts 2003–2018 LLC "FIRN M". All rights reserved. The site contains information only on medical topics.